MCID: FBR003
MIFTS: 41

Fibrous Histiocytoma

Categories: Cancer diseases

Aliases & Classifications for Fibrous Histiocytoma

MalaCards integrated aliases for Fibrous Histiocytoma:

Name: Fibrous Histiocytoma 12 14
Histiocytoma, Benign Fibrous 42 69
Benign Fibrous Histiocytoma 12
Fibrous Histiocytoma Nos 12
Histiocytoma Fibrous 52
Fibroxanthoma Nos 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4415
MeSH 42 D018219
NCIt 47 C3739
UMLS 69 C0206644

Summaries for Fibrous Histiocytoma

MalaCards based summary : Fibrous Histiocytoma, also known as histiocytoma, benign fibrous, is related to histiocytoma and hemangioma. An important gene associated with Fibrous Histiocytoma is ATF1 (Activating Transcription Factor 1), and among its related pathways/superpathways are Transcriptional misregulation in cancer and Striated Muscle Contraction. The drugs Doxorubicin and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and lung.

Wikipedia : 72 Benign fibrous histiocytomas (also known as dermal dendrocytoma,dermatofibroma,fibrous... more...

Related Diseases for Fibrous Histiocytoma

Diseases related to Fibrous Histiocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 239)
id Related Disease Score Top Affiliating Genes
1 histiocytoma 31.5 ACTC1 DES VIM
2 hemangioma 30.4 F13A1 VIM
3 chondroblastoma 29.9 DES VIM
4 spindle cell sarcoma 27.1 ATF1 CD163 CREB1 EWSR1 FUS MFHAS1
5 diaphyseal medullary stenosis with malignant fibrous histiocytoma 12.6
6 cutaneous fibrous histiocytoma 12.3
7 malignant fibrous histiocytoma of bone 12.2
8 malignant skin fibrous histiocytoma 12.1
9 benign deep fibrous histiocytoma 12.0
10 undifferentiated pleomorphic sarcoma 12.0
11 histiocytoma, angiomatoid fibrous, somatic 11.8
12 sclerosing hemangioma 11.4
13 myxofibrosarcoma 11.3
14 malignant fibroxanthoma 11.0
15 tenosynovial giant cell tumor 11.0
16 urachal cancer 11.0
17 thymus large cell carcinoma 10.7 EWSR1 FUS
18 transverse colon cancer 10.6 EWSR1 FUS
19 clear cell chondrosarcoma 10.6 EWSR1 MTAP
20 sparse hair-short stature-skin anomalies syndrome 10.6 DES FUS
21 infantile scoliosis 10.5 DES VIM
22 parkinsonism with dementia of guadeloupe 10.5 ATF1 CREB1 EWSR1
23 lymphocytic infiltrate of jessner 10.5 DES VIM
24 intellectual disability-polydactyly-uncombable hair syndrome 10.5 DES VIM
25 pineal region yolk sac tumor 10.5 DES VIM
26 mannose-binding lectin protein deficiency 10.5 DES VIM
27 sarcoma 10.5
28 cortical blindness 10.5 F13A1 VIM
29 vitamin d-dependent rickets, type i 10.4 ATF1 EWSR1 FUS
30 space motion sickness 10.4 DES VIM
31 noninvasive malignant thymoma 10.4 F13A1 VIM
32 childhood pleomorphic rhabdomyosarcoma 10.4 DES VIM
33 vulvar squamous papilloma 10.4 DES VIM
34 submandibular adenitis 10.4 EWSR1 FUS
35 hunter carpenter macdonald syndrome 10.4 ATF1 CREB1
36 neuromuscular junction disease 10.4 DES F13A1
37 rectal neoplasm 10.4 DES VIM
38 extraskeletal mesenchymal chondrosarcoma 10.4 DES VIM
39 cataract congenital autosomal dominant 10.4 DES F13A1
40 myoepithelial carcinoma 10.4 DES VIM
41 mucin-rich endometrial endometrioid adenocarcinoma 10.3 DES VIM
42 lymphocytic hypophysitis 10.3 ACTC1 VIM
43 gastric signet ring cell adenocarcinoma 10.3 ACTC1 VIM
44 cellular ependymoma 10.3 DES EWSR1 VIM
45 aneurysm 10.3
46 marfanoid habitus-inguinal hernia-advanced bone age syndrome 10.3 ACTC1 DES
47 lymphangiosarcoma 10.3 ACTC1 VIM
48 tracheo-esophageal fistula-hypospadias syndrome 10.2 ACTC1 F13A1
49 oligomeganephronic renal hypoplasia 10.2 SERPINA3 VIM
50 liposarcoma 10.2

Graphical network of the top 20 diseases related to Fibrous Histiocytoma:



Diseases related to Fibrous Histiocytoma

Symptoms & Phenotypes for Fibrous Histiocytoma

Drugs & Therapeutics for Fibrous Histiocytoma

Drugs for Fibrous Histiocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 91)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
2
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
3
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
4
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
5
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
6
Dactinomycin Approved Phase 3 50-76-0 2019 457193
7
Epirubicin Approved Phase 3 56420-45-2 41867
8
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
9
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
10
Lenograstim Approved Phase 3 135968-09-1
11
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
12
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
13 Alkylating Agents Phase 3,Phase 2,Phase 1
14 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
15 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
16 Isophosphamide mustard Phase 3,Phase 2,Phase 1
17 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
18 Anti-Infective Agents Phase 3,Phase 2,Phase 1
19 Antimitotic Agents Phase 3
20 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
21 Antirheumatic Agents Phase 3,Phase 2,Phase 1
22 Etoposide phosphate Phase 3,Phase 2
23 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
24 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
25
Indinavir Approved Phase 2 150378-17-9 5362440
26
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
27
Dacarbazine Approved, Investigational Phase 2 4342-03-4 5351166
28
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
29
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
30
Bevacizumab Approved, Investigational Phase 2 216974-75-3
31
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
32
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
33
Everolimus Approved Phase 1, Phase 2 159351-69-6 6442177
34
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
35
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 5284616 6436030 46835353
36
Cisplatin Approved Phase 2 15663-27-1 84093 441203 2767
37
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
38
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
39
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
40
Nicotinamide Approved, Nutraceutical Phase 2 98-92-0 936
41
leucovorin Approved, Nutraceutical Phase 2 58-05-9 143 6006
42
Saracatinib Investigational Phase 2 379231-04-6
43 Soblidotin Investigational Phase 2 149606-27-9
44
Camptothecin Experimental Phase 2 7689-03-4
45 Exatecan Investigational Phase 2 171335-80-1
46 Anti-HIV Agents Phase 2
47 Anti-Retroviral Agents Phase 2
48 Antiviral Agents Phase 2
49 Cytochrome P-450 CYP3A Inhibitors Phase 2
50 Cytochrome P-450 Enzyme Inhibitors Phase 2

Interventional clinical trials:

(show all 44)

id Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
3 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
4 Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Completed NCT00091351 Phase 3
5 Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00061984 Phase 3 doxorubicin hydrochloride;ifosfamide
6 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
7 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3 doxorubicin hydrochloride;etoposide;ifosfamide
8 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
9 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
10 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Recruiting NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
11 Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Recruiting NCT01344018 Phase 3
12 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
13 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
14 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
15 Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma Unknown status NCT00410462 Phase 2 brostallicin;doxorubicin hydrochloride
16 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
17 Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma Completed NCT00031915 Phase 2 imatinib mesylate
18 Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Completed NCT00400569 Phase 2 Sunitinib Malate (SU011248)
19 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
20 Bevacizumab and Radiation Therapy for Sarcomas Completed NCT00356031 Phase 2 Bevacizumab
21 Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung Completed NCT00503295 Phase 2
22 Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma Completed NCT00085475 Phase 2 imatinib mesylate
23 AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2 saracatinib
24 Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Completed NCT00245102 Phase 2 sorafenib tosylate
25 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
26 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
27 Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Completed NCT00949325 Phase 1, Phase 2 temsirolimus (Torisel) plus liposomal doxorubicin (Doxil)
28 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Completed NCT00526149 Phase 2 BI 2536
29 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
30 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
31 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
32 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
33 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
34 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Active, not recruiting NCT00667342 Phase 2 Cisplatin;Doxorubicin;Methotrexate;Ifosfamide;etoposide
35 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
36 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
37 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
38 Vaccine Therapy in Treating Patients With Metastatic Cancer Completed NCT00020267 Phase 1 interleukin-2;MAGE-12 peptide vaccine;Montanide ISA-51
39 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
40 Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX Unknown status NCT00900211
41 Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone Completed NCT00007046
42 Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy Completed NCT01674101
43 PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma Active, not recruiting NCT00346125 doxorubicin hydrochloride;ifosfamide;pegylated liposomal doxorubicin hydrochloride
44 Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma Withdrawn NCT00334984 glutamine

Search NIH Clinical Center for Fibrous Histiocytoma

Cochrane evidence based reviews: histiocytoma, benign fibrous

Genetic Tests for Fibrous Histiocytoma

Anatomical Context for Fibrous Histiocytoma

MalaCards organs/tissues related to Fibrous Histiocytoma:

39
Bone, Skin, Lung, Breast, Liver, Heart, Brain

Publications for Fibrous Histiocytoma

Articles related to Fibrous Histiocytoma:

(show top 50) (show all 842)
id Title Authors Year
1
A Rare Case of Malignant Fibrous Histiocytoma (Undifferentiated High-Grade Pleomorphic Sarcoma) of Malar Region. ( 28468216 )
2017
2
Deep Benign Fibrous Histiocytoma of the Anterior Mediastinum Mimicking Malignancy. ( 28497381 )
2017
3
Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. ( 28536856 )
2017
4
CORR Insights(Ar): Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. ( 28656494 )
2017
5
Cholesterotic fibrous histiocytoma with no associated dyslipidemia. ( 28303567 )
2017
6
Malignant fibrous histiocytoma arising from renal capsule: An extremely rare entity. ( 28937382 )
2017
7
Dermoscopy and reflectance confocal microscopy of osteoclastic deep benign fibrous histiocytoma. ( 28895663 )
2017
8
Two cases of benign fibrous histiocytomas (dermatofibromas) associated with Langerhans cell histiocytosis. ( 28941307 )
2017
9
Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? ( 28281318 )
2017
10
Treatment outcomes of malignant fibrous histiocytoma of the maxillary sinus. ( 28901310 )
2017
11
18F-FDG Uptake in Benign Fibrous Histiocytoma of Adrenal Gland: A Potential Pitfall. ( 28632691 )
2017
12
TLE-1-Positive Angiomatoid Fibrous Histiocytoma Mimicking Synovial Sarcoma. ( 28248724 )
2017
13
Benign Fibrous Histiocytoma: An Uncommon Presentation. ( 28892910 )
2017
14
Primary pulmonary malignant fibrous histiocytoma: case report and literature review. ( 28932590 )
2017
15
Aneurysmal Variant of Fibrous Histiocytoma- A Rare Entity Known for Recurrence. ( 28764178 )
2017
16
Angiomatoid fibrous histiocytoma of the scalp mimicking cutaneous angiosarcoma in incisional biopsy containing CD31-positive histiocytes: A potential histopathological pitfall. ( 28370384 )
2017
17
Primary hepatic malignant fibrous histiocytoma combined with invasion of inferior vena cava: A case report and literature review. ( 28591058 )
2017
18
Malignant fibrous histiocytoma masquerading as pyogenic granuloma. ( 28388346 )
2017
19
Aneurysmal fibrous histiocytoma - spindle cell tumour with pigment: A diagnostic dilemma on cytology. ( 28727241 )
2017
20
Angiomatoid fibrous histiocytoma: Clinicopathological spectrum of five cases, including EWSR1-CREB1 positive result in a single case. ( 27166030 )
2016
21
Intraspinal extradural benign fibrous histiocytoma of the lumbar spine in a pediatric patient. Case report and literature review. ( 26984808 )
2016
22
Benign Fibrous Histiocytoma of the Frontal Bone. ( 27054431 )
2016
23
Malignant fibrous histiocytoma of the skin. A case treated with radiotherapy. ( 26837483 )
2016
24
Primary malignant fibrous histiocytoma of the liver. ( 27826563 )
2016
25
Primary malignant fibrous histiocytoma of the colon: A case report and review of the literature. ( 27284436 )
2016
26
Benign Fibrous Histiocytoma: A Rare Case Report and Literature Review. ( 26929563 )
2016
27
Angiomatoid fibrous histiocytoma: A case of local recurrence and metastases to loco-regional lymph nodes that responded to chemotherapy. ( 28012233 )
2016
28
An unresectable retroperitoneal malignant fibrous histiocytoma: A case report. ( 27073487 )
2016
29
A case of recurrent malignant fibrous histiocytoma of the mesentery. ( 27351621 )
2016
30
Benign Fibrous Histiocytoma of Mandible: A Case Report and Updated Review. ( 27504429 )
2016
31
Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report. ( 26917971 )
2016
32
'Pure' spindle cell variant of angiomatoid fibrous histiocytoma, lacking classic histologic features. ( 27637157 )
2016
33
Primary malignant fibrous histiocytoma of long bones: long-term follow-up. ( 27499321 )
2016
34
ALK Rearrangement and Overexpression in an Unusual Cutaneous Epithelioid Tumor With a Peculiar Whorled "Perineurioma-like" Growth Pattern: Epithelioid Fibrous Histiocytoma. ( 27438515 )
2016
35
Double primary malignant fibrous histiocytoma and squamous cell carcinoma of the larynx treated with laser laryngeal conservation surgery. ( 27170836 )
2016
36
Subcutaneous Benign Fibrous Histiocytoma: Rare Presentation on Cheek-Case Report and Review of Literature. ( 27408454 )
2016
37
Malignant fibrous histiocytoma of the skin: a case treated with radiotherapy. ( 27176091 )
2016
38
Fibrous Histiocytoma of the Conjunctiva. ( 27636240 )
2016
39
Angiomatoid fibrous histiocytoma: novel MR imaging findings. ( 26919861 )
2016
40
Deep Penetrating Fibrous Histiocytoma: A Case Report and Implications for Surgical Management. ( 26999346 )
2016
41
Intracranial Angiomatoid Fibrous Histiocytoma: Case Report and Literature Review. ( 27667574 )
2016
42
Primary Angiomatoid Fibrous Histiocytoma of the Lung with Mediastinal Lymph Node Metastasis. ( 27544801 )
2016
43
Computed tomography and magnetic resonance imaging findings of malignant fibrous histiocytoma of the head and neck. ( 27123302 )
2016
44
Conjunctival fibrous histiocytoma in an 8-year-old boy. ( 27282913 )
2016
45
Malignant Fibrous Histiocytoma of the Testicular Appendages Mimicking an Obstructed Hernia in an Elderly Man: Case Report and Review of the Literature. ( 26953736 )
2016
46
14-Year-Old Boy With Mild Antecedent Neck Pain in Setting of Acute Trauma: A Rare Case of Benign Fibrous Histiocytoma of the Spine. ( 26991583 )
2016
47
Reconstruction of the elbow by Baksi sloppy hinge total elbow prosthesis following excision of a malignant fibrous histiocytoma. ( 26566346 )
2015
48
Malignant fibrous histiocytoma of maxillary sinus- a diagnostic challenge. ( 27217674 )
2015
49
Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT. ( 26053714 )
2015
50
Benign fibrous histiocytoma of the ethmoids in an infant. ( 26265837 )
2015

Variations for Fibrous Histiocytoma

Expression for Fibrous Histiocytoma

Search GEO for disease gene expression data for Fibrous Histiocytoma.

Pathways for Fibrous Histiocytoma

Pathways related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.51 ATF1 EWSR1 FUS MITF
2 11.19 ACTC1 DES VIM
3 10.54 ATF1 CREB1
4 10.34 ATF1 CREB1 MITF

GO Terms for Fibrous Histiocytoma

Cellular components related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 blood microparticle GO:0072562 8.8 ACTC1 F13A1 SERPINA3

Biological processes related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 acute-phase response GO:0006953 9.16 CD163 SERPINA3
2 intermediate filament organization GO:0045109 8.96 DES VIM
3 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.02 CREB1 DES EWSR1 FUS VIM

Sources for Fibrous Histiocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....